Equasens SA
SWB:PHF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Equasens SA (PHF) under the Base Case is 36.65 EUR per share.
Compared with the current market price of 27.55 EUR, the stock appears
Undervalued by 25% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Equasens Does
Equasens SA is a French software and technology company focused on the healthcare sector. It builds and sells digital tools that help pharmacies, doctors, nurses, hospitals, and care facilities manage prescriptions, patient records, billing, and day-to-day administration. Its products are designed to sit inside the workflow of healthcare professionals, so the company is less of a general IT vendor and more of a specialist provider for regulated medical and pharmacy businesses.
- Headquarters
- France FR
- Employees
- 1 400
- IPO date
- Oct 20, 2000
Equasens has no economic moat
Equasens SA lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysisBalance Sheet
Continue PHF Research
Decided on Equasens? Get an email when PHF reaches the price you’d buy at. Free with an account.
Other Equasens listings
What is the Intrinsic Value of one PHF stock?
The intrinsic value for
Equasens SA (PHF) under the Base Case is 36.65 EUR.
Is PHF stock undervalued or overvalued?
Compared with the current market price of 27.55 EUR, the stock appears Undervalued by 25% .